Key result
Proper design and conduct of phase II trials are critical for evaluating treatments such as sorafenib in patients with soft tissue sarcomas like angiosarcoma.
Answers are grounded in this paper and cite their sources.
This editorial emphasizes the importance of proper design and conduct of phase II trials in soft tissue sarcoma.
A phase II study with sorafenib in patients with angiosarcoma conducted by the French Sarcoma Group, and published in this issue of The Oncologist, is evaluated. The importance of proper design and conduct of phase II trials is stressed.
No takes yet. Share an insight, caveat, or question.
Stefan Sleijfer (2012) studied this question. Proper design and conduct of phase II trials are critical for evaluating treatments such as sorafenib in patients with soft tissue sarcomas like angiosarcoma.
Synapse has enriched 10 related papers. Consider them for comparative context: